Dr. Weiming Xia

Biography

Weiming Xia completed his graduate studies at the University of Texas Medical School at Houston, earning both his Master's and PhD degrees in Biochemistry and Molecular Biology. Following his academic pursuits, he underwent postdoctoral training focused on Alzheimer’s disease (AD) at Brigham and Women’s Hospital, associated with Harvard Medical School. In 1999, he was appointed as an Assistant Professor in Neurology at Harvard Medical School, where he established an NIH-funded research laboratory specializing in Alzheimer's disease. In 2012, he transitioned to the Department of Veterans Affairs Bedford VA Medical Center, where he leads an independent laboratory dedicated to exploring the molecular mechanisms and biomarkers of Alzheimer's disease. His research centers on target identification, characterization, and validation within early-stage drug development, with an emphasis on clinical biomarkers for Alzheimer’s disease. Dr. Xia has created multiple platforms to quantitatively assess pathological proteins, including amyloid beta protein, Tau, and various neuroinflammatory factors, while developing Mass Spectrometry-based analytic methods to investigate these biomarkers related to central nervous system disorders.

Research Interests

Experience